Emmanuelle Charpentier
PhD
Founding and Scientific Director, Max Planck Unit for the Science of Pathogens
👥Biography 个人简介
Emmanuelle Charpentier shared the 2020 Nobel Prize in Chemistry for the co-discovery of CRISPR-Cas9 as a genome editing tool. Her foundational characterization of tracrRNA and the Cas9 mechanism enabled the programmable genome editing revolution. She co-founded CRISPR Therapeutics to translate CRISPR into medicines including cancer applications.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Emmanuelle Charpentier 的研究动态
Follow Emmanuelle Charpentier's research updates
留下邮箱，当我们发布与 Emmanuelle Charpentier（Max Planck Institute for Infection Biology）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment